Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
NCT00265850
Colonic Diseases, Colonic Neoplasms
Mobile, Alabama, United States
View Trial DetailsNCT Number: NCT00966667
RATIONALE: Gathering information over time from patients who have finished treatment for colorectal cancer may help doctors predict which cancer survivors will improve their physical activity and diet.
PURPOSE: This clinical trial is studying health behaviors in patients who have finished treatment for stage I, stage II, or stage III colorectal cancer.
Looking for future studies?
Notify Me21 year and older
All sexes
Observational
Cooper Hospital/University Medical Center, Camden, New Jersey, United States
OBJECTIVES:
Primary
Secondary
OUTLINE: This is a multicenter study.
Patients complete surveys at baseline and at 3 and 6 months. A randomly selected subset of 84 patients also receive an activity monitor to be use at each of the 3 time points. The acceptability of their use is assessed and whether activity levels change across the 3 time points and the extent to which they are convergent with self-reported physical activity are examined.
During each survey, questionnaires are administered to assess the following areas: physical/medical characteristics (self-reported), self-efficacy for physical activity, fruit and vegetable consumption, and dietary fat intake; outcome expectations for physical activity, fruit and vegetable consumption, and dietary fat intake; physical activity and diet behavioral self-regulation; illness representations (causal attributions and controllability of recurrence); perceived risk of colorectal cancer (CRC) recurrence; emotional representations of CRC (cancer-related anxiety and worry about cancer recurrence); healthcare provider recommendations to alter physical activity and dietary intake; social influence from important others; current physical activity and dietary intake; and diet and physical activity program preferences. Patients who received the activity monitor are asked feedback on acceptability of them.
Measures of sociodemographics and disease/treatment characteristics (via medical chart review) are recorded.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Time frame: 3 yrs
Time frame: 3 yrs
Time frame: 3 yrs
Time frame: 3 yrs
Time frame: 3 yrs
Time frame: 3 yrs
Time frame: 3 yrs
Time frame: 3 yrs
Rutgers, The State University of New Jersey
Other
Health Behaviors Among Individuals Diagnosed With Colorectal Cancer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00265850
Colonic Diseases, Colonic Neoplasms
Mobile, Alabama, United States
View Trial DetailsNCT07725692
Anastomotic Leak, Colon Cancer
Alexandria, Please Select, Egypt
View Trial DetailsNCT00102011
Colonic Diseases, Colonic Neoplasms
Shreveport, Louisiana, United States
View Trial DetailsNCT00556413
Colonic Diseases, Colonic Neoplasms
Montpellier, France
View Trial Details